News 2024
Ensymm aquires new pharma and food supplement suppliers/distributers for Lactase powder in Netherland and Greece
Ensymm accomplish two bankable techno-financial feasibility studies for its Egyptian client Bellfood company with the Topic “Setup a textured vegetable protein production line” and “ Setup a modern tomato paste production line”
Dr. Dehdari audit the facility of a pharma company in Slovakia to check the possibility of lactase drops production using Optiferm ready-mix bulk solution.
Dr. Dehdari hold a workshop/Seminar about chitosan project and business in 21st Century for a startup in Poland
Ensymm prepare and deliver a bankable techno-financial pre-feasibility study for the Topic ” industrial ducting and air handling production facility ” for a client in Riyad/ Saudi Arabia
Ensymm runs and submits a full lab/pilot scale trial and process dossier to a Technology Company in UAE for extracting chitosan/protein-pigment powder out of shrimp shells/heads from Indonesia
Dr. Dehdari is appointed as principal consultant for a biopharma consulting company in Austria
Ensymm accomplish two bankable techno-financial feasibility studies as a 2 in 1 combi study for its client NHF from Iraq with the Topic “Setup a biosimilar finish product facility ” and “ Setup a Peritoneal Dialysis production line”